BR
Therapeutic Areas
Luciole Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| OGG1 Activator Program | Neurodegenerative Diseases | Pre-clinical |
Leadership Team at Luciole Pharmaceuticals
DG
Dennis Goldberg, PhD
President, CEO, Director, Co-founder
EM
Eric Morrel, PhD
Vice President, COO, Director, Co-founder